A novel bovine lactoferrin peptide, FKCRRWQWRM, suppresses Candida cell growth and activates neutrophils

Journal of Peptide Research

Volumn 57, Issue 3, 2001, Pages 240-249

  Ueta, E ^a   Tanida, T ^a   Osaki, T ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Candida albicans; Candida killing; FKCRRWQWRM; Lactoferrin peptides; Neutrophils

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; ARGINYLARGINYLTRYPTOPHYLGLUTAMYLTRYPTOPHYLARGININE; ARGINYLTRYPTOPHYLGLUTAMYLTRYPTOPHYLARGINYLMETHIONINE; GLYCYLALANYLPROLYLSERYLISOLEUCYLTHREONYLCYSTEINYLVALYLARGINYLARGINYLALANYLP HENYLALANINE; LACTOFERRICIN B; LACTOFERRIN; MICONAZOLE; MITOGEN ACTIVATED PROTEIN KINASE; PHENYLALANYLLYSYLALANYLARGINYLARGINYLTRYPTOPHYLGLUTAMYLTRYPTOPHYLARGINYLMET HIONINE; PHENYLALANYLLYSYLCYSTEINYLARGINYLARGINYLTRYPTOPHYLGLUTAMYLTRYPTOPHYLARGINYL METHIONINE; PROTEIN KINASE C; UNCLASSIFIED DRUG;

ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CELL KILLING; CONTROLLED STUDY; DRUG POTENCY; ENZYME ACTIVITY; FUNGUS GROWTH; IRON TRANSPORT; LEUKOCYTE ACTIVATION; MINIMUM INHIBITORY CONCENTRATION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMALS; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CATTLE; CELL DIVISION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IRON; LACTOFERRIN; MICROBIAL SENSITIVITY TESTS; MITOGEN-ACTIVATED PROTEIN KINASES; MOLECULAR SEQUENCE DATA; NADPH OXIDASE; NEUTROPHIL ACTIVATION; NEUTROPHILS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PEPTIDE FRAGMENTS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN KINASE C; SUPEROXIDES; TYROSINE; UP-REGULATION;

BOVINAE; CANDIDA; CANDIDA ALBICANS; FUNGI;

EID: 0035083899     PISSN: 1397002X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3011.2001.057003240.x     Document Type: Article

References (57)

1. Molecular diagnosis and epidemiology of fungal infections
2. Oral mycosis in HIV infection
3. Oral infections and fever in immunocompromised patients with haematologic malignancies
4. Trend in antifungal use and epidemiology of nosocomial yeast infections in a university hospital
5. Fungal pneumonia in transplant recipients
6. Oral pathoses caused by Candida albicans during chemotherapy: Update on development mechanisms
7. Fungal infections of the small and large intestine
8. Clinical and pathological investigation of opportunistic pulmonary mycoses in autopsy cases
9. Reduced inhibition of Candida albicans adhesion by saliva from patients receiving oral cancer therapy
10. Effects of dietary sugars and saliva and serum on Candida biofilm formation on acrylic surfaces
11. Cumulative correlations of lysozyme, lactoferrin, peroxidase, s-IgA, amylase, and total protein concentrations with adherence of oral viridans streptococci to microplates coated with human saliva
12. The relationship between salivary histatin levels and oral yeast carriage
13. Fungicidal effect of human lactoferrin against Candida albicans
14. The effect of secretory immunoglobulin A on the in-vitro adherence of the yeast Candida albicans to human oral epithelial cells
15. Human salivary histatins: Promising anti-fungal therapeutic agents
16. The antifungal effect of lactoferrin and lysozyme on Candida krusei and Candida albicans
17. Functions of salivary polymorphonuclear leukocytes (SPMNs) and peripheral blood polymorphonuclear leukocytes (PPMNs) from healthy individuals and oral cancer patients
18. Metal-combining properties of human lactoferrin (red milk protein). 1. The involvement of bicarbonate in the reaction
19. Lactoferrin, lactoferrin receptors and iron metabolism
20. Lactoferrin markedly inhibits hepatitis C virus infection in cultured human hepatocytes
21. Antiviral effects of mild proteins: Acylation results in polyanionic compounds with potent activity against human immunodeficiency virus types 1 and 2 in vitro
22. Oral administration of bovine lactoferrin for treatment of intractable stomatitis in feline immunodeficiency virus (FIV)-positive and FIV-negative cats
23. Apoptosis in human leukemic cells induced by lactoferricin, a bovine milk protein-derived peptide: Involvement of reactive oxygen species
24. Bovine lactoferrin and lactoferricin, a peptide derived from bovine lactoferrin, inhibit tumor metastasis in mice
25. Plasma lactoferrin reflects granulocyte activation in vivo
26. Neutrophil granulocytes in acute bacterial infection. Sequential studies on lysozyme, myeloperoxidase and lactoferrin
27. Identification of the bactericidal domain of lactoferrin
28. Structure-biological activity relationships of 11-residue highly basic peptide segment of bovine lactoferrin
29. Cationic amphipathic peptides, derived from bovine and human lactoferrins, with antimicrobial activity against oral pathogens
30. Response and specificity of antibodies for Candida albicans
31. Evaluation of the Sensititre system for quantitative antimicrobial drug susceptibility testing: A collaborative study
32. Isolation of mononuclear cells and granulocytes from human blood: Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g
33. Quantitative nitroblue tetrazolium reduction by normal newborn monocytes
34. Extracellular adenosine nucleotides stimulate protein kinase C activity and human neutrophil activation
35. Infections in the compromised host
36. Cellular immunity in recurrent vulvovaginal candidiasis
37. An evolution of therapy for mucocutaneous candidiasis
38. Reactivity of Candida albicans germ tubes with salivary secretory IgA
39. The in vitro lysozyme susceptibility of Candida albicans cultured in carbohydrate-supplemented media
40. Augmented inhibition of growth of Candida albicans by neutrophils in the presence of lactoferrin
41. Anti Candida activity of induced transferrin in mice immunized with inactivated Candida albicans
42. An iron binding protein common to many external secretions
43. Iron binding proteins in milk and resistance to Escherichia coli infection in infants
44. Inhibition of mastitic bacteria by bovine milk apolactoferrin evaluated by in-vitro microassay of bacterial growth
45. Bactericidal activity of lactoferrin: Differentiation from the stasis of iron deprivation
46. Damage of the outer membrane of enteric gram-negative bacteria by lactoferrin and transferrin
47. Three-dimensional solution structure of lactoferricin B, an antimicrobial peptide derived from bovine lactoferrin
48. Cooprerative anti-Candida effects of lactoferrin or its peptides in combination with azole antifungal agents
49. Antimicrobial peptide pores in membranes detected by neutron in-plane scattering
50. Disseminated candidiasis due to amphotericin B-resistant Candida albicans
51. Modulation of neutrophil function in host defense against disseminated Candida albicans infection in mice
52. Therapeutic efficacy of human macrophage colony-stimulating factor, used alone and in combination with antifungal agents, in mice with systemic Candida albicans infection
53. Interaction and intracellular killing of Candida albicans blastospores by human polymorphonuclear leukocytes, monocytes, and monocyte-derived macrophages in aerobic and anaerobic conditions
54. Exposure of macrophages to an enzymatically inactive macrophage mannose receptor ligand augments killing of Candida albicans
55. 3-K in the signaling pathways of NADPH oxidase activation and phagocytosis in bovine polymorphonuclear leukocytes
56. Chronic granulomatous disease: The solving of a clinical riddle at the molecular level
57. Hydrophobic moments in protein structure